Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia. (PubMed, N Engl J Med) - Sep 17, 2026 - P3 | "In children with newly diagnosed high-risk B-cell ALL, replacement of two cycles of highly toxic conventional chemotherapy with blinatumomab resulted in a significantly greater percentage of patients with event-free survival at 4 years. (Funded by Deutsche Krebshilfe and others; AIEOP-BFM ALL 2017 EudraCT number, 2016-001935-12; EU Clinical Trials number, 2023-509856-32-00; and ClinicalTrials.gov number, NCT03643276.)."
Clinical • Journal • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Infectious Disease • Leukemia • Oncology • Pediatrics
|
|
; Alexandra Kolenová; Andishe Attarbaschi; Andrea Biondi; Anja Möricke; Anke Bergmann; Arend von Stackelberg; Arndt Borkhardt; Barbara Buldini; Carmelo Rizzari; Claudia Rössig; Daniela Silvestri; Draga Barbaric; Faraz Zaman; Fiona Poyer; Franca Fagioli; Franco Locatelli; Gerhard Zugmaier; Giovanni Cazzaniga; Grazia Fazio; Gunnar Cario; Jan Stary; Jean-Pierre Bourquin; Julia Alten; Laura Rachele Bettini; Luciana Vinti; Luciano Dalla-Pozza; Lucie Sramkova; Maria Caterina Putti; Maria Grazia Valsecchi; Martin Schrappe; Martin Stanulla; Martin Zimmermann; Michaela Vossen-Gajcy; Monika Brüggemann; Nicole Bodmer; Patrick Hundsdörfer; Rolf Köhler; Rosanna Parasole; Sarah Elitzur; Valentino Conter
|